A
ARCH Venture Partners
Focus: Robotics & hardware, Healthtech & bioARCH Venture Partners took part in 2 of the startup funding rounds we tracked in 2026, leading or co-leading 1 worth $300m. By money raised, its biggest sectors were Robotics & hardware and Healthtech & bio. The largest was Oratomic's $300m Series A round. The most recent was Encoded Therapeutics's Series D+ round in September 2026.
Deployed as lead$300m
Rounds led1
Rounds joined2
Largest round$300m